Pages that link to "Q40789167"
Jump to navigation
Jump to search
The following pages link to Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells (Q40789167):
Displaying 29 items.
- Pitavastatin in cardiometabolic disease: therapeutic profile (Q21246037) (← links)
- Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor (Q28202918) (← links)
- Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study (Q28254501) (← links)
- Pitavastatin and carbohydrate metabolism: what is the evidence? (Q30251801) (← links)
- Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia (Q33902665) (← links)
- Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals (Q34614726) (← links)
- Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia. (Q34625887) (← links)
- Pitavastatin: evidence for its place in treatment of hypercholesterolemia (Q34628242) (← links)
- Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus (Q34999753) (← links)
- Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study) (Q35009357) (← links)
- Comparison of efficacy of intensive versus mild pitavastatin therapy on lipid and inflammation biomarkers in hypertensive patients with dyslipidemia (Q35106600) (← links)
- Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients (Q35508337) (← links)
- Fluvastatin: clinical and safety profile (Q35807245) (← links)
- Pitavastatin: finding its place in therapy (Q36443716) (← links)
- Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men. (Q37413198) (← links)
- New evidence on pitavastatin: efficacy and safety in clinical studies (Q37702244) (← links)
- Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia (Q37776512) (← links)
- Pitavastatin - pharmacological profile from early phase studies (Q37824750) (← links)
- Are all statins the same? Focus on the efficacy and tolerability of pitavastatin (Q37859000) (← links)
- Pitavastatin: an overview (Q37966064) (← links)
- Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia (Q37987212) (← links)
- Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and low-density lipoprotein on proliferation and migration of keratinocytes (Q42467407) (← links)
- Occlusal disharmony accelerates the initiation of atherosclerosis in apoE knockout rats. (Q42914650) (← links)
- Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus (Q44193427) (← links)
- A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits (Q45068304) (← links)
- Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs. (Q51810075) (← links)
- Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol (Q58701054) (← links)
- Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects (Q82741763) (← links)
- A Rapidly Progressive Case of Statin-induced Necrotizing Autoimmune Myopathy (Q90642189) (← links)